TBP AUDIO FILES
AI-generated audio files
TBP AUDIO FILES
Bleeding Phenotype Across Life Stages in von Willebrand Disease
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
I want you to imagine uh a medical condition that basically acts like a shapeshifter.
SPEAKER_00Oh wow. Okay.
SPEAKER_01Yeah. Think about this. So when you're 10 years old, this condition looks like a really simple, annoying nosebleed.
SPEAKER_00Right. Just typical kid stuff.
SPEAKER_01Exactly. But by the time you're 17, it has morphed into severe fatigue and incredibly heavy periods.
SPEAKER_00That is quite the jump.
SPEAKER_01Right. And then fast forward to age 28, and it seems to just miraculously cure itself, like completely gone.
SPEAKER_00I mean, that sounds impossible.
SPEAKER_01But wait, it gets weirder because then at age 60, it vanishes from your lab tests entirely while somehow causing a completely new set of dangerous systemic problems.
SPEAKER_00Aaron Powell Well, I mean, it sounds like an absolute diagnostic nightmare, honestly. We are so conditioned by modern medicine to think of a disease as you know a static entity. Trevor Burrus, Jr.: Binary, right? Yeah, binary. You have the genetic mutation, therefore you have the disease, and it's just going to look like X for the rest of your life.
SPEAKER_01Aaron Powell We expect our biology to be this fixed list of symptoms we just sort of carry around with us in a backpack.
SPEAKER_00Aaron Powell Right. Which just isn't reality.
SPEAKER_01Aaron Powell It's really not. But welcome to today's deep dive, where we are going to completely reframe how you think about chronic illness. We have an incredibly fascinating article in front of us today by William Ayrd, focusing on Von Willebrand disease or VWD.
SPEAKER_00It is such a great piece.
SPEAKER_01Aaron Powell It really is. And the mission today is to show you that a diagnosis isn't always a fixed label. Sometimes it's this dynamic, fluid interaction between your biology and your timeline. Okay, let's unpack this. Because to understand how a disease can actually shape shift over decades, we have to fundamentally redefine what it means to, you know, have von Willebrand disease in the first place.
SPEAKER_00Aaron Ross Powell We really do. And to move past that static view, Aired introduces this crucial concept of hemostatic reserve.
SPEAKER_01Hemostatic reserve.
SPEAKER_00Right. So when someone has von Willebrand disease, they have a reduction in von Willebrand factor, which is the adhesive glycoprotein that uh tethers platelets to damaged endothelium.
SPEAKER_01It's basically the blood's glue.
SPEAKER_00Aaron Powell Exactly, the glue. But the key to the whole shape-shifting illusion is that having a lower baseline level of VWF doesn't actually mean you are constantly bleeding.
SPEAKER_01Oh, interesting.
SPEAKER_00Yeah, it just means your overall reserve-like, your system's capacity to maintain hemostasis when it's actively challenged is reduced.
SPEAKER_01Aaron Powell Okay, let me try an analogy here. It's kind of like a bridge with a compromised weight limit.
SPEAKER_00I like that.
SPEAKER_01So the bribs looks perfectly fine on a sunny Tuesday when, you know, just a few bicycles are crossing it. The structural flaw is completely invisible because the demand is so low.
SPEAKER_00Right. The system isn't being stressed.
SPEAKER_01Exactly. You only discover that the bridge is compromised when a fleet of 18 wheelers tries to cross it all at exactly the same time. The structural integrity didn't suddenly change on that day. I mean, the flaw was always there in the concrete. It just finally faced a challenge big enough to reveal the limited reserve.
SPEAKER_00If we connect this to the bigger picture, that analogy perfectly captures why the central diagnostic question for a hematologist shouldn't just be uh, does this patient have VWD? The better, much more accurate question is what life stage is testing this patient's hemostatic reserve right now?
SPEAKER_01Oh, that is such a good way to frame it.
SPEAKER_00The disease isn't just moving through time, time is actively modifying how the disease appears. It's really a combination of three forces. You have the patient's underlying biologic modulation, the physical challenges they face, and the interpretive context surrounding their symptoms.
SPEAKER_01Okay, let's dig into that biologic baseline first. Because the article points out that even before we get to the 18 wheelers crossing the bridge, your baseline reserve isn't just determined by the VWD mutation itself.
SPEAKER_00No, it's not.
SPEAKER_01There are other biological modulators. And the one that really stood out to me was ABO blood type.
SPEAKER_00Oh yeah, that is a huge factor.
SPEAKER_01How does a patient's blood type dictate a clotting factor? Like are typo patients clearing the protein from their blood faster, or are they just, I don't know, producing less of it from birth?
SPEAKER_00It's a clearance issue, actually, and the mechanism is fascinating. So von Willebrand factor is a heavily glycosylated protein, meaning it's covered in these carbohydrate structures.
SPEAKER_01Okay, sugar tags.
SPEAKER_00Right, sugar tags. For individuals with blood type A or B, those specific A and B antigens are actually expressed on the VWF molecule itself.
SPEAKER_01Oh, I had no idea.
SPEAKER_00Yeah. But blood group O individuals completely lack those sugar tags. And because their VWF lacks those structures, it is far more susceptible to being cleared from the circulation by the liver.
SPEAKER_01Wow. So their bodies manufacture the glue just fine, but because it's missing those specific sugar tags, their own clearance pathways just sort of sweep it into the garbage at a much faster rate?
SPEAKER_00Effectively, yes. Group O individuals have VWF levels that are roughly 25 to 30% lower than non-O individuals.
SPEAKER_01That's a huge drop.
SPEAKER_00It is. And that's simply as a baseline. So right out of the gate, your underlying everyday biology is modulating your hemostatic reserve, completely independent of the VWD mutation itself.
SPEAKER_01Okay, so that sets the biological stage. But going back to the bridge analogy, a low baseline doesn't actually matter until the bridge is tested.
SPEAKER_00Exactly.
SPEAKER_01What are the 18 wheelers in a patient's life that actually expose this flaw? If we look at this chronologically, you know, starting in childhood, it seems like the diagnostic challenge is that the big tests just haven't arrived yet.
SPEAKER_00Precisely. In a child, the bleeding phenotype is really ambiguous. It's just emerging.
SPEAKER_01Because kids are messy.
SPEAKER_00Right. A child with VWD might have uh recurrent epistaxis or prolonged bleeding when they lose a baby tooth. But pediatricians face a massive signal to noise limitation here. Healthy kids bruise all the time.
SPEAKER_01Yeah, they fall off bikes, they scrape their knees.
SPEAKER_00Exactly. They get nosebleeds just from dry air in the winter. Aired mentions the use of bleeding assessment tools or BT scores, which are used to quantify a patient's bleeding history.
SPEAKER_01Right, like a survey.
SPEAKER_00But in pediatrics, a low score on that tool isn't necessarily reassuring.
SPEAKER_01Aaron Powell Because a negative bleeding history in an eight-year-old might simply reflect a total lack of exposure.
SPEAKER_00Yes.
SPEAKER_01If they haven't had their tonsils out or, you know, suffered major trauma, they haven't passed the test. The test just literally hasn't occurred yet.
SPEAKER_00Aaron Powell Which brings us to adolescence, where the first real, undeniable physiologic stress test finally happens.
SPEAKER_01Aaron Powell And we are talking specifically about females hitting Monarch.
SPEAKER_00Yes.
SPEAKER_01That monthly cycle acts as a massive stress test on the hemostatic system.
SPEAKER_00Aaron Powell It really does. For many patients, this is the very first time their von Willebrand disease becomes clinically visible and it presents as heavy menstrual bleeding.
SPEAKER_01And we aren't just talking about a heavy flow day.
SPEAKER_00No, we are talking about flooding, passing large clots, waking up in the middle of the night, missing school, and just profound chronic fatigue.
SPEAKER_01Aaron Powell See, I'm trying to square the genetics here, though. If von Willebrand disease is an autosomal disorder.
SPEAKER_00Aaron Powell Meaning it's passed down equally to males and females.
SPEAKER_01Right. So why is it suddenly treated almost exclusively as a women's health issue in adolescence? Does like estrogen actually degrade the clotting factor in some way, or is this purely a mechanical issue of blood volume?
SPEAKER_00It is overwhelmingly a mechanical and structural challenge. The genetics are not female-specific at all. Males and females inherit the defect equally. But males do not undergo the shedding of the highly vascularized endometrial lining every 28 days.
SPEAKER_01Right, the 18-wheeler.
SPEAKER_00Exactly. Yeah. The onset of menses doesn't create the disease, and hormones aren't degrading the VWF. It's just that the sheer physical demand required to achieve hemostasis in the uterus exposes the limited reserve that was already there.
SPEAKER_01And this leads to massive iron deficiency. Aired is very clear about the diagnostic trap here. A normal hemoglobin is basically useless here if you aren't checking the ferritin right.
SPEAKER_00Yes, absolutely useless.
SPEAKER_01They are going to tank their iron stores long before the hemoglobin actually drops.
SPEAKER_00The body ruthlessly prioritizes maintaining that active circulating hemoglobin. It will pull from ferritin reserves in the tissues until there is absolutely nothing left.
SPEAKER_01Wow.
SPEAKER_00So presenting with a normal hemoglobin, but a tank ferritin level is a blaring red flag that the hemostatic reserve is failing under the pressure of menstruation.
SPEAKER_01But this introduces what Aired calls the interpretive context, right? Like the subjective story told about the objective biology.
SPEAKER_00Right, the human element.
SPEAKER_01A teenager carrying extra clothes to school and just accepting chronic fatigue as a normal part of growing up. That is a massive failure of interpretive context.
SPEAKER_00Aaron Powell It is a systemic failure. Heavy menstrual bleeding needs to be treated as hematologic evidence.
SPEAKER_01Evidence of a bleeding disorder.
SPEAKER_00Exactly. Too often it is dismissed as just a gynecologic annoyance, or a mother might say, Well, my periods were heavy too. That's just normal for our family.
SPEAKER_01Right, because the mother might be undiagnosed too.
SPEAKER_00Exactly. Repetition does not make heavy bleeding physiologically normal. Yeah. It just makes it easier to overlook.
SPEAKER_01So by adolescence, the disease has usually declared itself for those facing that monthly test, and you'd intuitively think that once a genetic illness is obvious, it stays obvious.
SPEAKER_00You would think so.
SPEAKER_01But this is where the shape shifting kicks into high gear. Let's look at the reproductive years, specifically pregnancy. Because pregnancy plays a profound biologic trick on laboratory tests.
SPEAKER_00It's one of the clearest demonstrations of a dynamic phenotype. During pregnancy, a patient's biology undergoes radical shifts to prepare for the massive vascular event of childbirth. Which makes sense. Right. Endothelial cells just ramp up production. For many patients, particularly those with type 1 VWD, their endogenous levels of von Wilbrand factor and factor eighth actually rise substantially as the pregnancy progresses.
SPEAKER_01So by the third trimester, if a hematologist draws blood from that patient, their VWF levels might look completely perfectly normal?
SPEAKER_00Yes. The laboratory values will often normalize entirely. But pregnancy does not cure the underlying genetic defect.
SPEAKER_01It's just a mask.
SPEAKER_00Exactly. It simply alters the vascular environment temporarily.
SPEAKER_01But hold on. If we know pregnancy artificially inflates these numbers to mask the baseline deficiency, why are doctors even looking at third trimester labs to assess bleeding risk? Aren't they just setting themselves up for a false sense of security right before the patient goes into labor?
SPEAKER_00This raises an important question about how we interpret dynamic medical data. A physician who relies solely on a reassuring antipartum number is making a dangerous error.
SPEAKER_01They're looking at the wrong snapshot.
SPEAKER_00Exactly. They must anticipate the risk based on the patient's pre-pregnancy baseline levels and their historical bleeding phenotype. The third trimester snapshot is a total illusion, and the medical team have to be prepared for the postpartum crash.
SPEAKER_01Because what goes up must come down. Once the placenta is delivered, those hormones shift again.
SPEAKER_00Dramatically. Within a matter of days after delivery, those elevated VWF levels plummet back down to the patient's compromised baseline.
SPEAKER_01Oh wow, just days.
SPEAKER_00Days. As the pregnancy-associated hemostatic protections recede, the patient enters a highly vulnerable window. This is where we see primary and secondary postpartum hemorrhage or dangerously prolonged lochia.
SPEAKER_01That creates a massive blind spot. The patient gets a clean bill of health right at the moment their body is masking the defect, practically guaranteeing the medical team will be caught off guard if they aren't looking at the patient's entire timeline.
SPEAKER_00It's terrifying when it's missed.
SPEAKER_01It perfectly proves Eric's point, though. A single blood test on a random Tuesday is just a snapshot. It's not the reality of the disease.
SPEAKER_00And as we move forward in the timeline into adulthood, the reality of the disease shifts again. For many adults, VWD actually transitions into a situational bleeding disorder.
SPEAKER_01Because the nature of the 18-wheelers changes. Adults generally aren't scraping their knees on the playground and they move past the childbearing years. They might subjectively report to a doctor, oh, I don't really bleed.
SPEAKER_00But they mean they don't bleed spontaneously.
SPEAKER_01Right.
SPEAKER_00The adult history has to be read entirely as a history of exposures. Their baseline reserve is still low, but it's just waiting for a situational challenge.
SPEAKER_01Like what?
SPEAKER_00A tooth extraction. A gastrointestinal biopsy. The disease is quiet until a surgeon's scalpel tests the reserve.
SPEAKER_01Here's where it gets really interesting, though. Let's talk about aging. Because as a patient simply gets older, the shape shifter pulls its final trick. A patient diagnosed with type 1 EWD at age 12 might walk into a clinic at age 60, get their blood drawn, and have totally normal VWF levels.
SPEAKER_00It happens all the time.
SPEAKER_01Why does the protein naturally rise as we age?
SPEAKER_00It's largely due to endothelial wear and tear over decades, coupled with chronic, low-grade inflammation that just naturally accompanies aging.
SPEAKER_01So the blood vessels are just stress out.
SPEAKER_00Basically, yes. The endothelium essentially becomes more reactive, releasing more VWF into the plasma. The laboratory normalization with age is a heavily documented phenomenon.
SPEAKER_01But undiagnosing them at age 60 based on that one blood test could be incredibly dangerous, right? Just when their labs look normal, their real-world risk of catastrophic bleeding is actually escalating.
SPEAKER_00The paradox of aging with VWD is that while the lab values improve, the hemostatic system is suddenly under attack from multiple new directions. Older adults develop acquired bleeding risks.
SPEAKER_01Right, other diseases start popping up.
SPEAKER_00Exactly. They are more likely to develop gastrointestinal vascular lesions like angiodysplasia, which are notorious for bleeding. They develop comorbidities like renal disease that impair platelet function. And critically, they are frequently prescribed antiplatelet medications or anticoagulants for cardiovascular issues.
SPEAKER_01Speaking of cardiovascular issues, AIR dives into acquired von Wilbrand syndrome. And I want to make sure we hit this because this isn't the germline mutation they were born with. This is a completely new version of the disease acquired through the sheer physics of aging.
SPEAKER_00It is, and it's wild. High shear cardiovascular states can physically induce the syndrome.
SPEAKER_01High shear meaning like extreme pressure.
SPEAKER_00Yes. Think of older adults who develop severe aortic stenosis, or patients who require an LVAD, which is a mechanical left ventricular assist device.
SPEAKER_01A heart pump.
SPEAKER_00Right.
SPEAKER_01So it's not a genetic failure at all. It's like putting a long string of yarn through a blender. The mechanical violence of the mechanical pump, or the blood forcing its way through a calcified narrowed valve, is literally shredding the clotting glue before the body can even use it.
SPEAKER_00That is exactly what happens on a molecular level.
SPEAKER_01Wait, literally shredding it.
SPEAKER_00Literally. Von Willebrand factor circulates as these massive coiled multiprobers. When blood is forced through a narrowed valve or churned by an impeller in an L V A D, the high shear stress physically unfolds the VWF protein.
SPEAKER_01Oh, it stretches it out?
SPEAKER_00Yes. And once it's stretched out, an enzyme in the blood called Ada MTS13 quickly cleaves it, basically shredding it into smaller, far less functional pieces.
SPEAKER_01Wow.
SPEAKER_00You acquire a severe deficiency not from your DNA, but from fluid dynamics.
SPEAKER_01It's incredible. Aging can simultaneously mask the genetic version of the disease on a lab test while physically creating a new acquired version through wear and tear on the heart. I do want to clarify though, Aired notes that this dynamic shifting primarily applies to mild or moderate VWD. Severe VWD or type three operates a bit differently, right?
SPEAKER_00Yes, it does. The severity of the baseline defect really matters. In type three VWD, the von Willebrand factor is virtually absent from birth.
SPEAKER_01Okay, so there is no reserve?
SPEAKER_00None. And consequently, factor eight is remarkably low, since VWF normally protects factor eight from degradation. For type three patients, the reserve is so depleted that the disease is highly visible early on. We see deep muscle hematomas and hemarthrosis, which is bleeding directly into the joint spaces.
SPEAKER_01Ouch. But even with type three, they aren't outside of time, right? The baseline is drastically lower, but the timeline still dictates when those severe vulnerabilities are exposed. Like Minarch is still a massive challenge. Surgical interventions still require precise timing and factor replacement.
SPEAKER_00Exactly. The severity sets the baseline, but the life stage still modifies the expression.
SPEAKER_01When you lay out all these distinct phases, from the childhood bruises to the heart valves at age 70, it sounds like we're talking about completely different diseases.
SPEAKER_00It really has.
SPEAKER_01If we tracked one single patient through this entire gauntlet, what would their medical chart actually look like over a lifetime? Airod includes a specific case study that perfectly synthesizes this.
SPEAKER_00I love this case study. It's a brilliant way to ground the science in a lived experience.
SPEAKER_01Walk us through it.
SPEAKER_00So we look at a single female patient. At age 12, she presents with recurrent epistaxis and bruising. Her labs show a VWF antigen level of 42 and an activity level of 39. She is diagnosed with mild type 1 VWD.
SPEAKER_01Okay, so the biology is a mild deficiency, and the challenge is typical childhood trauma. But then at age 17, she develops heavy menstrual bleeding and severe iron deficiency.
SPEAKER_00Right, the onset of the adolescent stress test. Her genotype hasn't changed, but the hemostatic challenge of menstruation has completely overwhelmed her limited reserve. And the systemic failure to recognize her heavy bleeding as a bleeding disorder delays her proper hematologic care.
SPEAKER_01Tragic, but common. Then at age 28, she becomes pregnant. Her VWF levels shoot up to 95. The laboratory illusion of a cure.
SPEAKER_00Physiologic modulation at work. The hormonal shifts of pregnancy have completely masked the baseline deficiency, giving everyone a false sense of security.
SPEAKER_01Which leaves directly to age 34, when, after her second delivery, she suffers delayed postpartum bleeding. The biological masking wore off, and the physical trauma of childbirth shattered her reserve. Finally, at age 55, she goes in for a routine checkup. Her VWF levels have naturally crept up to 78, well within the normal range, and she reports no spontaneous bleeding.
SPEAKER_00Looking at that chart, the core reflection question is Did this woman have four different diseases over the course of her life?
SPEAKER_01No. Her germline genotype like, the exact DNA sequence she was born with remained completely constant from day one.
SPEAKER_00What changed was the biology, you know, the hormonal shifts of pregnancy, the endothelial changes of aging, what changed was the physical exposure, childbirth, menses, dental work. And what changed was the interpretive context, what symptoms were minimized by doctors and which were acted upon. Time itself is literally part of her phenotype.
SPEAKER_01And that brings us to the core mission of this deep dive. Von Willebrand disease proves that a diagnosis is a dynamic vulnerability. You cannot assume that a mild childhood means you'll have a mild adulthood.
SPEAKER_00Never.
SPEAKER_01And you certainly can't assume that a normalized lab test at age 60 means the disease is magically gone.
SPEAKER_00It requires a massive paradigm shift in how we view our medical history. Your medical history isn't just a static list of underlying conditions, it must be read as a history of your exposures.
SPEAKER_01A timeline of the 18 Wheelers.
SPEAKER_00Exactly. It's the ongoing narrative of how your unique biology reacts to the specific physical challenges your life throws at it.
SPEAKER_01And why should you, the listener, care about this? Because understanding this dynamic interaction completely changes how you must advocate for your own health. It teaches us that a single blood test is just a snapshot. It is not the whole movie.
SPEAKER_00That is so true.
SPEAKER_01If a specialist looks at a lab result and tells you everything looks normal, but you know your history, you know how your body reacted to a tooth extraction or how it failed to recover from a heavy period, you have to speak up. You are the only one who has lived through the timeline, and you are the only one who holds the full context of your hemostatic reserve.
SPEAKER_00We really do rely too heavily on the snapshot. Recognizing that diseases evolve with us over time is uh really the only way to anticipate risks before they become emergencies.
SPEAKER_01I want to leave you with a final thought to mull over today. If time, environment, and physical milestones like pregnancy or aging can so effectively mask or reveal a known documented genetic blood disorder.
SPEAKER_00Oh, I see where you're going with this.
SPEAKER_01Right. It makes you wonder what other subtle, undiscovered genetic vulnerabilities are hiding in our DNA right now. Are there traits, immune responses, or metabolic flaws, just waiting for the exact right combination of age and environmental stress to suddenly wake up and become visible in our lives?
SPEAKER_00It's a profound question. We assume we understand our bodies, but maybe we only know how they react to the 18 wheelers they face so far.
SPEAKER_01The bridge might look totally fine today, but you never know what the traffic of tomorrow might reveal. Thanks for joining us on this deep dive. See you next time.